These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28237642)

  • 21. Distance between the rectal wall and mesorectal fascia measured by MRI: Effect of rectal distension and implications for preoperative prediction of a tumour-free circumferential resection margin.
    Slater A; Halligan S; Taylor SA; Marshall M
    Clin Radiol; 2006 Jan; 61(1):65-70. PubMed ID: 16356818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rectal cancer staging: Multidetector-row computed tomography diagnostic accuracy in assessment of mesorectal fascia invasion.
    Ippolito D; Drago SG; Franzesi CT; Fior D; Sironi S
    World J Gastroenterol; 2016 May; 22(20):4891-900. PubMed ID: 27239115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical implication of negative conversion of predicted circumferential resection margin status after preoperative chemoradiotherapy for locally advanced rectal cancer.
    Lee NK; Kim CY; Park YJ; Yang DS; Yoon WS; Kim SH; Kim J
    Eur J Radiol; 2014 Feb; 83(2):245-9. PubMed ID: 24268789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of MRI for predicting the circumferential resection margin, mesorectal fascia invasion, and tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Kim SH; Lee JM; Park HS; Eun HW; Han JK; Choi BI
    J Magn Reson Imaging; 2009 May; 29(5):1093-101. PubMed ID: 19388124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer.
    Chau I; Brown G; Cunningham D; Tait D; Wotherspoon A; Norman AR; Tebbutt N; Hill M; Ross PJ; Massey A; Oates J
    J Clin Oncol; 2006 Feb; 24(4):668-74. PubMed ID: 16446339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.
    Kim NK; Baik SH; Seong JS; Kim H; Roh JK; Lee KY; Sohn SK; Cho CH
    Ann Surg; 2006 Dec; 244(6):1024-30. PubMed ID: 17122629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging defined mucinous rectal carcinoma is an independent imaging biomarker for poor prognosis and poor response to preoperative chemoradiotherapy.
    Yu SK; Chand M; Tait DM; Brown G
    Eur J Cancer; 2014 Mar; 50(5):920-7. PubMed ID: 24440086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of mesorectal volume in staging of rectal cancer with magnetic resonance imaging and the assessment of involvement of the mesorectal fascia.
    Torkzad MR; Hansson KA; Lindholm J; Martling A; Blomqvist L
    Eur Radiol; 2007 Jul; 17(7):1694-9. PubMed ID: 17186247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of the EMD/mesorectum ratio of T3 mid-low rectal cancer: A retrospective observational study.
    Gu C; Yang X; Zhang X; Zheng E; Deng X; Hu T; Wu Q; Bi L; Wu B; Su M; Wang Z
    Medicine (Baltimore); 2018 Nov; 97(48):e13468. PubMed ID: 30508974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local excision in mid-to-low rectal cancer patients who revealed clinically total or near-total regression after preoperative chemoradiotherapy; a proposed trial.
    Lee JL; Lim SB; Yu CS; Park IJ; Yoon YS; Kim CW; Park SH; Lee JS; Hong YS; Kim SY; Kim JE; Kim JH; Park JH; Kim J; Han M
    BMC Cancer; 2019 Apr; 19(1):404. PubMed ID: 31035949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accuracy of pre-treatment locoregional rectal cancer staging in a national improvement project.
    Op de Beeck B; Smeets P; Penninckx F; Pattyn P; Silversmit G; Van Eycken E;
    Acta Chir Belg; 2017 Apr; 117(2):104-109. PubMed ID: 27881048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic value of fourth-generation iterative reconstruction algorithm with low-dose CT protocol in assessment of mesorectal fascia invasion in rectal cancer: comparison with magnetic resonance.
    Ippolito D; Drago SG; Talei Franzesi CR; Casiraghi A; Sironi S
    Abdom Radiol (NY); 2017 Sep; 42(9):2251-2260. PubMed ID: 28429055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of a preoperative magnetic resonance imaging assessment of the distance of mesorectal extension in clinical T3 lower rectal cancer.
    Sueda T; Ohue M; Noura S; Shingai T; Nakanishi K; Yano M
    Surg Today; 2016 Nov; 46(11):1249-57. PubMed ID: 26769241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectral presaturation inversion recovery MR imaging sequence after gadolinium injection to differentiate fibrotic scar tissue and neoplastic strands in the mesorectal fat in patients undergoing restaging of rectal carcinoma after neoadjuvant chemo- and radiation therapy.
    Quaia E; Ulcigrai V; Coss M; De Paoli L; Ukmar M; Zanconati F; De Pellegrin A; De Manzini N; Cova MA
    Acad Radiol; 2011 Nov; 18(11):1365-75. PubMed ID: 21971257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to treatment and interval to surgery after preoperative short-course radiotherapy in rectal cancer.
    García-Cabezas S; Rodríguez-Liñán M; Otero-Romero AM; Bueno-Serrano CM; Gómez-Barbadillo J; Palacios-Eito A
    Cir Esp; 2016 Oct; 94(8):460-6. PubMed ID: 27461232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
    Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A
    Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selection of Patients With Rectal Cancer for Preoperative Chemoradiotherapy: Are T Category and Nodal Status All That Matters?
    Pooni A; Al-Sukhni E; Milot L; Fruitman M; Victor JC; Schmocker S; Brown G; Kennedy E
    Dis Colon Rectum; 2019 Apr; 62(4):447-453. PubMed ID: 30451758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiation with delayed surgery in the treatment of rectal cancer: a systematic review and meta-analysis.
    Zhou ZR; Liu SX; Zhang TS; Chen LX; Xia J; Hu ZD; Li B
    Surg Oncol; 2014 Dec; 23(4):211-21. PubMed ID: 25466851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is it time to rethink the rule of total mesorectal excision? A prospective radiological and pathological study in 49 consecutive patients with mid-rectal cancer.
    Guedj N; Zappa M; Maggiori L; Bertin C; Hennequin C; Panis Y
    Colorectal Dis; 2016 Sep; 18(9):O314-21. PubMed ID: 27381492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.